To investigate the structural basis underlying potency and selectivity of a series of novel analogues of thieno[2,3-d]pyrimidin-4-yl hydrazones as cyclin-dependent kinase 4 (CDK4) inhibitors and to ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback